Essential role of insulin-like growth factor 2 in resistance to histone deacetylase inhibitors

Histone deacetylase inhibitors (HDIs) are promising anticancer therapies and have been clinically used for the treatment of hematological malignancy. However, their efficacy in solid tumors is marginal and drug resistance hampers their further clinical utility. To develop novel strategies for the HD...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Su-Chan, Min, Hye-Young, Jung, Hyun Jin, Park, Kwan Hee, Hyun, Seung Yeob, Cho, Jaebeom, Woo, Jong Kyu, Kwon, So Jung, Lee, Hyo-Jong, Lee, Ho-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069101/
https://www.ncbi.nlm.nih.gov/pubmed/27086926
http://dx.doi.org/10.1038/onc.2016.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069101/
https://www.ncbi.nlm.nih.gov/pubmed/27086926
http://dx.doi.org/10.1038/onc.2016.92

Ejemplares similares